Lipoid nephrosis in childhood;Néphrose lipoïdique de l'enfant

Revue du Praticien

Volumn 53, Issue 18, 2003, Pages 2027-2032

  Niaudet, Patrick ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

BACTERIAL INFECTION; CHILD HEALTH CARE; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HYPOVOLEMIA; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIPOID NEPHROSIS; NEPHROTIC SYNDROME; PROLIFERATIVE GLOMERULONEPHRITIS; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; SHOCK; STEROID THERAPY; THROMBOEMBOLISM;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; BIOPSY; CHILD; CYCLOSPORINS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PREDNISONE; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0347513046     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 1993; 152: 357-61.
2. Hodson EM, Knight JF, Willis NS, Craig JC. Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. Arch Dis Child 2000; 83: 45-51.
3. British Association for Pediatric Nephrology. Levamisole for corticosteroid dependent nephrotic syndrome in childhood. Lancet 1991; 337: 1555-7.
4. British Association for Paediatric Nephrology. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Arch Dis Child 1994; 70: 151-7.
5. Barratt TM, Soothill JF. Controlled trial of cyclophosphamide in steroid sensitive relapsing nephrotic syndrome of childhood. Lancet 1970; ii: 479-82.
6. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Cyclophosphamide treatment of steroid dependant nephrotic syndrome: comparison of eight weeks with 12 weeks course. Arch Dis Child 1987; 62: 1102-6.
7. Niaudet P, Habib R. Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 1994; 5: 1049-56.
8. Choi MJ, Eustace JA, Gimenez LF et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002; 61: 1098-114.
9. Fakhouri F, Bocquet N, Taupin P et al. Steroid sensitive nephritic syndrome: from childhood to adulthood. Am J Kidney Dis 2003; 41: 550-7.
10. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349-54.
11. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-6.
12. Tune BM, Kirpekar RK, Reznik VM, Grisfold WR, Mendoza SA. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 1995; 43: 84-8.
13. Tarshish P, Tobin JN, Bernstein J, Edelman CM. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1996; 10: 590-3.
14. Niaudet P and The French Society of Pediatric Nephrology. Treatment of childhood steroid resistant idiopathic nephrosis with a combinaison of cyclosporine and prednisone. J Pediatr 1994; 125: 981-5.
15. Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation in children. Transplantation 2003; 75: 810-4.